ClinicalTrials.gg
RecruitingNCT07489690Updated Mar 24, 2026

Energy Dense Fueling for Cold-Weather Operations

An interventional study of High Fat and High Carbohydrate in Cold Exposure, sponsored by United States Army Research Institute of Environmental Medicine. Recruiting at 1 site in United States. Open to participants aged 18 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-24.

Sponsored by United States Army Research Institute of Environmental Medicine · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Feb 2026; still recruiting 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
8
Allocation
Randomized
Ages
18 Years to 39 Years
Sex
All
01

Study summary

High daily energy expenditures without compensatory increases in energy intakes results in severe energy deficits during cold-weather military operations. Observational and experimental data from our laboratory suggests that consuming higher-fat, energy dense products can increase energy intake and attenuate energy deficits, however, laboratory analysis is needed to understand the impact of macronutrient manipulation on substrate oxidation and aerobic performance. This proof of concept, randomized crossover study will examine the effects of consuming an isocaloric bar (approximately 350 kcal) that is higher in carbohydrate (CHO: 50% carbohydrate, 30% fat, 20% protein) or higher in fat (FAT: 30% carbohydrate, 50% fat, 20% protein) on substrate oxidation and aerobic performance (time trial) during acute cold (5°C) exposure. Volunteers will wear shorts and a t-shirt during cold exposure, with continuous monitoring of core and skin temperatures. Baseline data will be collected on volunteer height, weight, body composition, and V̇O2peak. To ensure volunteers are familiar with exercise protocols, they will complete practice sessions of all exercise before the start of data collection. Exercise and diet will be controlled throughout data collection. 24 hours prior to data collection, volunteers will consume a lead-in study diet and will abstain from exercise. After 24 hours, volunteers will return to the laboratory for assessment of substrate oxidation and aerobic performance. Volunteers will consume the CHO or FAT treatment bars under cold conditions, followed by 60 minutes of rest prior to the start of exercise. Volunteers will then complete 90 minutes of load carriage steady-state (55 ± 5% VO2peak) treadmill exercise, wearing a ruck with weighing 30% of their total body mass. After steady-state exercise, aerobic performance will be assessed by having volunteers complete a 2-mile time trial. Indirect calorimetry will be used to determine substrate oxidation during steady-state exercise. Serial blood draws will be collected during each trial to assess circulating substrate/hormone responses. Protocol days will be separated by a minimum washout period of 6 days.

Read the detailed description

This randomized crossover double blind control study will examine the effects of consuming an isocaloric bar (approximately 350 kcal) that is higher in carbohydrate (CHO: 50% carbohydrate, 30% fat, 20% protein) or higher in fat (FAT: 30% carbohydrate, 50% fat, 20% protein) on substrate oxidation and aerobic performance (time trial) during acute cold (5°C; Climatic Chamber, Natick, MA) exposure.

The order of the treatment bar assignments will be randomized. Randomization will be created using a random numbers generator (http://randomization.com or similar). Only a designated study staff member will be unblinded to the code for the treatment bars. Volunteers will wear shorts and a t-shirt for all study procedures.

Baseline data will be collected on volunteer height, weight, body composition (dual energy x-ray absorptiometry), and V̇O2peak. To ensure volunteers are familiar with exercise protocols, they will complete practice sessions of all exercise before the start of data collection. Exercise and diet will be controlled throughout data collection. 24 hours prior to data protocol days, volunteers will consume a lead-in study diet and will abstain from exercise. After 24 hours, volunteers will return to the laboratory for assessment of substrate oxidation and aerobic performance. Volunteers will consume the CHO or FAT treatment under cold conditions, followed by a 60 min rest to induced physiological cold responses prior to the start of exercise. Volunteers will then complete 90 min of load carriage (30% body mass) steady-state (55 ± 5% V̇O2peak) treadmill exercise. Indirect calorimetry will be used to determine substrate oxidation during steady-state exercise. Serial blood draws will be collected during each trial to assess circulating substrate/hormone responses. After steady-state exercise, aerobic performance will be assessed by having volunteers complete a 2-mile time trial. There will be a minimum washout period of 6 days.

02

Conditions studied

  • Cold Exposure

Keywords

  • endurance exercise
  • dietary fat
  • dietary carbohydrate
03

In context

Lead sponsor

United States Army Research Institute of Environmental Medicine is the lead sponsor of 68 studies on the registry; 7 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: • Men and women aged 18 - 39 years (17 if active Military)

  • Physically active (exercise minimum 2 days per week)
  • Have supervisor approval (permanent party military and civilians at NSSC)
  • Willing to refrain from alcohol, nicotine products and dietary supplement use while on study diets
  • Females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual cycles within the past 6 months; or using oral/hormonal which contains low-dose estrogen/progesterone to maintain continuous levels throughout the 28-day cycle (i.e., no placebos)
  • Only consume caffeine products while on study diets if provided by study staff
  • (BMI) between 18.5-30 kg/m2
  • In good health as determined by OMSO (Office of Medical Support and Oversight)

Exclusion Criteria:

  • Metabolic or cardiovascular abnormalities, gastrointestinal disorders (i.e., kidney disease, diabetes, cardiovascular disease, hypertension etc.) that is unsuitable for the study determined by OMSO
  • Disease or medication (i.e., diabetes medications, statins, , etc) that affects macronutrient utilization and/or the ability to participate in strenuous exercise
  • Allergies or intolerance to foods (including but not limited to lactose intolerance/milk allergy), vegetarian practices
  • Present condition of alcoholism, anabolic steroids (testosterone, enanthate, undecanoate, etc), or other substance abuse issues
  • Unwilling to stop use of nutritional/sports supplements (creatine, multivitamins, whey etc.) while enrolled in the study
  • Sensitivity to medical adhesives resulting in significant skin irritation
  • Acute or chronic musculoskeletal injury that compromises the ability to run and ruck march
  • History of disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis; or previous gastrointestinal surgery
  • Difficulty swallowing large pills or unwilling to insert rectal temperature sensor
  • Raynaud's syndrome.
  • History of cold injuries of any severity (e.g., frostbite, trench foot, chilblains) that puts the volunteers at increased risk for an adverse effect
  • Cold-induced bronchospasms/asthma
  • Blood donation within 8 weeks of the study
  • Unwillingness or inability to adhere to study exercise restrictions
  • Scheduled MRI within 2 weeks after completing test in cold
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
8 participants (estimated)

Study arms

  • Experimental
    Higher Fat Supplement Bar

    Higher Fat, then High Carbohydrate

    Dietary Supplement: High Fat

  • Placebo comparator
    Higher Carbohydrate Supplement Bar

    High Carbohydrate, then High Fat

    Dietary Supplement: High Carbohydrate

Interventions

  • Dietary supplementHigh Fat

    Higher FatSupplement Bar

  • Dietary supplementHigh Carbohydrate

    Higher Carbohydrate Supplement Bar

06

What researchers measure

Primary outcomes

  1. Endurance Performance

    2 mile time trial run

    Time frame: 30 minutes

  2. Substrate Oxidation

    Respiratory Exchange Ratio

    Time frame: 90 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Margolis LM, Pasiakos SM. Performance nutrition for cold-weather military operations. Int J Circumpolar Health. 2023 Dec;82(1):2192392. doi: 10.1080/22423982.2023.2192392. PubMed 36934427 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07489690
Lead sponsor
United States Army Research Institute of Environmental Medicine
Responsible party
Sponsor
First posted
Mar 24, 2026
Start date
Feb 14, 2026
Primary completion
Jul 15, 2026 (estimated)
Completion
Sep 30, 2026 (estimated)
Last update
Mar 24, 2026

Study contacts

USARIEM Recruitment
Contact
USARMY.USARIEM-MNDstudies@health.mil
508-206-2278

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion